Document Detail


Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants.
MedLine Citation:
PMID:  17420209     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Saquinavir boosted with low-dose ritonavir given with zidovudine and lamivudine was well tolerated by pregnant women and their infants. All mothers had <400 human immunodeficiency virus type 1 RNA copies/ml at delivery. Two had elevated liver transaminases and amylase. Seven infant adverse events were possibly treatment related (anemia, neutropenia, and hyperbilirubinemia).
Authors:
Carmen D Zorrilla; Russell Van Dyke; Arlene Bardeguez; Edward P Acosta; Betsy Smith; Michael D Hughes; Sharon Huang; D Heather Watts; Barbara Heckman; Eleanor Jiménez; George McSherry; Lynne Mofenson
Related Documents :
19473489 - Human papillomavirus (hpv) infection in pregnant women and mother-to-child transmission...
9240869 - Overview of the potential role of vitamin a in mother-to-child transmission of hiv-1.
15249569 - Nevirapine and zidovudine at birth to reduce perinatal transmission of hiv in an africa...
12571529 - Quantitative rna testing for diagnosis of hiv-infected infants.
6421359 - Passive-active immunisation of neonates of hbsag positive carrier mothers: preliminary ...
23600719 - Comparison of the effect of human milk and topical hydrocortisone 1% on diaper dermatitis.
2504029 - Transcutaneous bilirubinometry in normal japanese infants.
17088699 - Comparability between icd-9 and icd-10 for the leading causes of death in spain.
20966409 - Cerebral oxygenation in preterm infants with germinal matrix-intraventricular hemorrhages.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2007-04-09
Journal Detail:
Title:  Antimicrobial agents and chemotherapy     Volume:  51     ISSN:  0066-4804     ISO Abbreviation:  Antimicrob. Agents Chemother.     Publication Date:  2007 Jun 
Date Detail:
Created Date:  2007-05-22     Completed Date:  2007-08-17     Revised Date:  2013-04-26    
Medline Journal Info:
Nlm Unique ID:  0315061     Medline TA:  Antimicrob Agents Chemother     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2208-10     Citation Subset:  IM    
Affiliation:
Obstetrics and Gynecology Department, UPR School of Medicine, P.O. Box 365067, San Juan, Puerto Rico. czorrilla@rcm.upr.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-HIV Agents* / administration & dosage,  adverse effects,  therapeutic use
Drug Therapy, Combination
Female
HIV Infections / drug therapy*,  virology
HIV-1 / drug effects
Humans
Infant
Infant, Newborn
Infectious Disease Transmission, Vertical / prevention & control
Microbial Sensitivity Tests
Mothers
Pregnancy
Pregnancy Complications, Infectious / drug therapy*,  virology
RNA, Viral / blood
Reverse Transcriptase Inhibitors* / administration & dosage,  adverse effects,  therapeutic use
Ritonavir* / administration & dosage,  adverse effects,  therapeutic use
Saquinavir* / administration & dosage,  adverse effects,  therapeutic use
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anti-HIV Agents; 0/RNA, Viral; 0/Reverse Transcriptase Inhibitors; 0/Ritonavir; 127779-20-8/Saquinavir
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endem...
Next Document:  In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylo...